Neuroendocrine tumors (NETs) are relatively rare neoplasms that can develop in many organ systems but predominantly affect the gastrointestinal tract, pancreas, and lung. However, incidence has increased more than sixfold in the United States over the last 4 decades. The combination of diverse clinical presentations of NETs in various body locations, nonspecific symptomatology, and relative rarity makes timely diagnosis and management challenging. Optimal diagnosis of NETs requires a well-coordinated multidisciplinary team to form a comprehensive diagnostic picture. Peptide receptor radionuclide therapy (PRRT) such as 177Lu-DOTATATE has been established as a standard of care treatment modality for some patients with NETs. In the context of targeted therapies, cabozantinib, an oral small-molecule inhibitor of multiple tyrosine kinases, recently received FDA approval for use after PRRT or everolimus. Join Dr. Jonathan Strosberg as he discusses the latest evidence and expert insights regarding the diagnosis and treatment of NETs and gastroenteropancreatic NETs.
Credit & MOC Details
Credit information is provided by the course provider. We recommend confirming credit eligibility with the provider or your licensing board before starting the activity.
Credit types
MOC types
FDA REMS
Qualifies for MIPS
Target Specialties
Pricing
100% of listed courses are free
36 of 36 courses listed here are free.
Collected from the provider’s public pages · source
Top 6 courses
-
-
-
-
-
-
Reflux Red Flags, and the Referral Riddle
0.25 Credits
Specialties served/covered
- Advanced Heart Failure & Transplant Cardiology
- Allergy & Clinical Immunology
- Cardiovascular Disease
- Dermatology
- Emergency Medicine
- Endocrinology, Diabetes & Metabolism
- Family Medicine
- Gastroenterology
- General & Adult Psychiatry
- General Pediatrics
- Hematology
- Interventional Cardiology
- Medical Oncology
- Metabolic & Bariatric Surgery
- Mood & Anxiety Disorders
- Neurology
- Ophthalmology
- Pulmonary Disease
- Rheumatology
- Surgical Oncology
- Cardio-Vascular
- Emergency & Critical Care
- GI & Liver
- Medical Subspecialties
- Neurology
- Oncology & Hematology
- Pediatrics
- Primary care
- Psychiatry
- Surgery
- No reviews yet. Be the first to share yours.
Pricing
Free
Reported to ACCME by the provider
- Enduring / On-demand
- Credit · Up to 1.25 credits
- Commercial Support
-
ReleasedJul 29, 2026
-
Last day to claim creditJul 30, 2027 10 months left
-
Learner’s Digest International (TM) Recent Advancements in Imaging and Treatment Options of Neuroendocrine Tumors
-
Plexus Communications +1 Navigating the Expanding NET Treatment Arsenal: Key Advances in Targeted Therapy & Nuclear Medicine
-
PRIME Education, Inc. (PRIME®) Clinical Pearls to Advance Multidisciplinary Team-Based Care for Patients With GEP-NETs
-
National Association for Continuing Education Modernizing Migraine Management: Moving Past Stagnant Treatment Patterns
-
National Association for Continuing Education Integrating TROP2-Directed ADCs into TNBC Treatment Plans: Novel Aspects of Efficacy and Safety Profiles
-
National Association for Continuing Education GPP in Focus: Early Recognition and Novel Therapies
